336 related articles for article (PubMed ID: 27718061)
1. Society of behavioral medicine supports increasing HPV vaccination uptake: an urgent opportunity for cancer prevention.
Peterson CE; Dykens JA; Brewer NT; Buscemi J; Watson K; Comer-Hagans D; Ramamonjiarivelo Z; Fitzgibbon M
Transl Behav Med; 2016 Dec; 6(4):672-675. PubMed ID: 27718061
[TBL] [Abstract][Full Text] [Related]
2. On surmounting the barriers to HPV vaccination: we can do better.
Attia AC; Wolf J; Núñez AE
Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccine in adolescent women: a 2012 update.
Etter DJ; Zimet GD; Rickert VI
Curr Opin Obstet Gynecol; 2012 Oct; 24(5):305-10. PubMed ID: 22781077
[TBL] [Abstract][Full Text] [Related]
4. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
Berkowitz Z; Malone M; Rodriguez J; Saraiya M
Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
[TBL] [Abstract][Full Text] [Related]
5. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.
Holman DM; Benard V; Roland KB; Watson M; Liddon N; Stokley S
JAMA Pediatr; 2014 Jan; 168(1):76-82. PubMed ID: 24276343
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus Vaccine as an Anticancer Vaccine: Collaborative Efforts to Promote Human Papillomavirus Vaccine in the National Comprehensive Cancer Control Program.
Townsend JS; Steele CB; Hayes N; Bhatt A; Moore AR
J Womens Health (Larchmt); 2017 Mar; 26(3):200-206. PubMed ID: 28263672
[TBL] [Abstract][Full Text] [Related]
7. Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015.
Mroz S; Zhang X; Williams M; Conlon A; LoConte NK
Prev Chronic Dis; 2017 Sep; 14():E85. PubMed ID: 28957034
[TBL] [Abstract][Full Text] [Related]
8. "It All Depends": A Qualitative Study of Parents' Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11-12 years.
Hansen CE; Credle M; Shapiro ED; Niccolai LM
J Cancer Educ; 2016 Mar; 31(1):147-52. PubMed ID: 25600376
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus Infection and Vaccination.
Valentino K; Poronsky CB
J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
[TBL] [Abstract][Full Text] [Related]
11. Engaging parents around vaccine confidence: proceedings from the National HPV Vaccination Roundtable meetings.
Perkins RB; Fisher-Borne M; Brewer NT
Hum Vaccin Immunother; 2019; 15(7-8):1639-1640. PubMed ID: 30188782
[TBL] [Abstract][Full Text] [Related]
12. HPV Vaccine-Related Knowledge, Beliefs, Acceptability, and Uptake Among Latinas Who Prefer English and Those Who Prefer Spanish.
Ashing KT; Chávez NR; Serrano M
J Health Commun; 2016 Dec; 21(12):1209-1216. PubMed ID: 27858522
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Health Care Professional Communication Training Intervention on Adolescent Human Papillomavirus Vaccination: A Cluster Randomized Clinical Trial.
Dempsey AF; Pyrznawoski J; Lockhart S; Barnard J; Campagna EJ; Garrett K; Fisher A; Dickinson LM; O'Leary ST
JAMA Pediatr; 2018 May; 172(5):e180016. PubMed ID: 29507952
[TBL] [Abstract][Full Text] [Related]
14. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
[TBL] [Abstract][Full Text] [Related]
15. Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians.
Santos ACDS; Silva NNT; Carneiro CM; Coura-Vital W; Lima AA
BMC Public Health; 2020 Mar; 20(1):301. PubMed ID: 32143614
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional survey of parental attitudes towards Human papillomavirus vaccination exclusion categories in Brazil.
Gattegno MV; Vertamatti MAF; Bednarczyk RA; Evans DP
BMC Int Health Hum Rights; 2019 Feb; 19(1):6. PubMed ID: 30819169
[TBL] [Abstract][Full Text] [Related]
17. Fatalistic beliefs and completion of the HPV vaccination series among a sample of young Appalachian Kentucky women.
Vanderpool RC; Dressler EV; Stradtman LR; Crosby RA
J Rural Health; 2015; 31(2):199-205. PubMed ID: 25640763
[TBL] [Abstract][Full Text] [Related]
18. Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines.
Vercruysse J; Chigurupati NL; Fung L; Apte G; Pierre-Joseph N; Perkins RB
Hum Vaccin Immunother; 2016 Jun; 12(6):1606-14. PubMed ID: 26934421
[TBL] [Abstract][Full Text] [Related]
19. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
[TBL] [Abstract][Full Text] [Related]
20. "HPV? Never heard of it!": a systematic review of girls' and parents' information needs, views and preferences about human papillomavirus vaccination.
Hendry M; Lewis R; Clements A; Damery S; Wilkinson C
Vaccine; 2013 Oct; 31(45):5152-67. PubMed ID: 24029117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
